Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Blood test could spot kidney cancer earlier, predict treatment success

NCT ID NCT06917560

Summary

This study is looking at whether patterns of certain antibodies in the blood can help doctors detect kidney cancer earlier and predict which patients might respond best to immunotherapy. Researchers are analyzing medical records and blood samples from 400 patients who have already been treated for kidney cancer. They aim to develop a model that could help personalize treatment decisions and improve patient outcomes.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RENAL CARCINOMA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • first hospital affiliated of Fujian medical university

    Fuzhou, Fujian, 350005, China

Conditions

Explore the condition pages connected to this study.